Literature DB >> 10592368

EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition.

H Boeing1, J Wahrendorf, N Becker.   

Abstract

The 'European Investigation into Cancer and Nutrition (EPIC)' represents one of the main scientific activities of the EU program 'Europe against Cancer' and is a large-scale cohort study on diet and chronic diseases, especially cancer, with approximately 475,000 study participants. The German contribution amounted to 53,000 study participants recruited between 1994 and 1998. The study instruments of the baseline examination included self-administered questionnaires for optical reading, PC-guided interviews, and physical examinations. These instruments covered different aspects of lifestyle, with a particular focus on diet. In addition, about 95% of the participants provided 30 ml of blood. The blood was stored in liquid nitrogen for further use, preferentially in nested case-control studies. All interviews and examinations were conducted by trained interviewers in examination centers established for this study in local health offices. Every 2 years, a follow-up questionnaire is mailed to the study participants. The follow-up questionnaires will be used as the major source of outcome information and to update exposure information. The self-reported diseases are verified by medical data. In the future, record linkage with local cancer registries will help to support the identification and collection of incident cancer cases. Only an outline of hypotheses was formulated at the very beginning of EPIC in 1992. In the future, each etiological study will be based on detailed research hypotheses according to the existing knowledge and identified research gaps. These studies will be conducted on cancer at the international level and on non-cancer diseases at the national or local level. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592368     DOI: 10.1159/000012786

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  91 in total

1.  Comparing the results of a cholesterol and saturated fat screener when using two different scores.

Authors:  Sabine Rohrmann; Gisela Klein
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Therese Truong; Rayjean J Hung; Christopher I Amos; Xifeng Wu; Heike Bickeböller; Albert Rosenberger; Wiebke Sauter; Thomas Illig; H-Erich Wichmann; Angela Risch; Hendrik Dienemann; Rudolph Kaaks; Ping Yang; Ruoxiang Jiang; John K Wiencke; Margaret Wrensch; Helen Hansen; Karl T Kelsey; Keitaro Matsuo; Kazuo Tajima; Ann G Schwartz; Angie Wenzlaff; Adeline Seow; Chen Ying; Andrea Staratschek-Jox; Peter Nürnberg; Erich Stoelben; Jürgen Wolf; Philip Lazarus; Joshua E Muscat; Carla J Gallagher; Shanbeh Zienolddiny; Aage Haugen; Henricus F M van der Heijden; Lambertus A Kiemeney; Dolores Isla; Jose Ignacio Mayordomo; Thorunn Rafnar; Kari Stefansson; Zuo-Feng Zhang; Shen-Chih Chang; Jin Hee Kim; Yun-Chul Hong; Eric J Duell; Angeline S Andrew; Flavio Lejbkowicz; Gad Rennert; Heiko Müller; Hermann Brenner; Loïc Le Marchand; Simone Benhamou; Christine Bouchardy; M Dawn Teare; Xiaoyan Xue; John McLaughlin; Geoffrey Liu; James D McKay; Paul Brennan; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2010-06-14       Impact factor: 13.506

3.  Weight cycling and the risk of type 2 diabetes in the EPIC-Germany cohort.

Authors:  Jasmine Neamat-Allah; Myrto Barrdahl; Anika Hüsing; Verena A Katzke; Ursula Bachlechner; Annika Steffen; Rudolf Kaaks; Matthias B Schulze; Heiner Boeing; Tilman Kühn
Journal:  Diabetologia       Date:  2015-09-16       Impact factor: 10.122

4.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

5.  Does pregnancy or pregnancy loss increase later maternal risk of diabetes?

Authors:  Elham Kharazmi; Annekatrin Lukanova; Birgit Teucher; Marie-Luise Groß; Rudolf Kaaks
Journal:  Eur J Epidemiol       Date:  2012-04-27       Impact factor: 8.082

6.  Dietary, lifestyle, and genetic determinants of vitamin D status: a cross-sectional analysis from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study.

Authors:  Tilman Kühn; Rudolf Kaaks; Birgit Teucher; Frank Hirche; Jutta Dierkes; Cornelia Weikert; Verena Katzke; Heiner Boeing; Gabriele I Stangl; Brian Buijsse
Journal:  Eur J Nutr       Date:  2013-09-05       Impact factor: 5.614

7.  Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.

Authors:  S Jacobs; K Schiller; E Jansen; A Fritsche; C Weikert; R di Giuseppe; H Boeing; M B Schulze; J Kröger
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

8.  Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.

Authors:  Matthew Schenk; Fabian Eichelmann; Matthias B Schulze; Natalia Rudovich; Andreas F Pfeiffer; Romina di Giuseppe; Heiner Boeing; Krasimira Aleksandrova
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

9.  Can the use of blood-based biomarkers in addition to anthropometric indices substantially improve the prediction of visceral fat volume as measured by magnetic resonance imaging?

Authors:  Jasmine Neamat-Allah; Theron Johnson; Diana Nabers; Anika Hüsing; Birgit Teucher; Verena Katzke; Stefan Delorme; Rudolf Kaaks; Tilman Kühn
Journal:  Eur J Nutr       Date:  2014-08-07       Impact factor: 5.614

10.  Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus.

Authors:  S van Dieren; U Nöthlings; Y T van der Schouw; A M W Spijkerman; G E H M Rutten; D L van der A; D Sluik; C Weikert; H G Joost; H Boeing; J W J Beulens
Journal:  Diabetologia       Date:  2010-10-20       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.